The variability of <scp><i>SMARCA4</i></scp>‐related <scp>Coffin–Siris</scp> syndrome: Do nonsense candidate variants add to milder phenotypes?
Dong Li(Children's Hospital of Philadelphia), Samantha A. Schrier Vergano(Children's Hospital of The King's Daughters), Benjamin Kamien(Services Australia), Sharron Townshend(King Edward Memorial Hospital), Alberto Fernández‐Jaén(Hospital Universitario Quirónsalud Madrid), Curtis Rogers(Greenwood Genetic Center), Constance Motter(Akron Children's Hospital), Matthew A. Deardorff(Children's Hospital of Philadelphia), Mahim Jain(Kennedy Krieger Institute), Janice Baker(Children's Minnesota), F. Ellis McKenzie(The University of Western Australia), Kirsten M. Niles(Hospital for Sick Children), Julie S. Cohen(Kennedy Krieger Institute), Maian Roifman(Hospital for Sick Children), Amy Calhoun(University of Iowa Stead Family Children’s Hospital), Rebecca C. Ahrens‐Nicklas(Children's Hospital of Philadelphia), Mark Mintz, Catherine Ward‐Melver(Akron Children's Hospital), Alyssa Ritter(Children's Hospital of Philadelphia), Vikas Bhambhani(Children's Minnesota)
Cited by 23
Related Papers
Whole-genome sequencing expands diagnostic utility and improves clinical management in paediatric medicine
|npj Genomic Medicine|2016|377
SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment
|Blood|2008|345
Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease
|New England Journal of Medicine|2025|272
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
|Nature Communications|2019|249
Heterozygous missense mutations in SMARCA2 cause Nicolaides-Baraitser syndrome
|Nature Genetics|2012|244